[68Ga]Ga-P17-079 in the Diagnosis and Treatment of Metastatic Prostate Cancer

Inclusion Criteria: * Male aged 18-85 years, expected survival ≥12 weeks. * Patients who have not undergone chemoradiotherapy, feasible surgery or biopsy to obtain a pathological diagnosis or are highly suspected of malignancy according to clinical diagnostic criteria. * At least one measurable target lesion was present according to RECIST1.1 criteria. * Obtain written informed consent and be able to follow up Exclusion Criteria: * Severe abnormal liver and kidney function * Fertile subjects will need to use effective contraception during the study * Unable to lie flat for half an hour * Refused to join this clinical investigator * Suffering from claustrophobia or other mental illness * Other conditions deemed unsuitable for participation in the trial